Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Limited has announced a new securities placement, with the intention to issue a maximum of 500,000 options expiring on 31st May 2027 at an exercise price of $0.93 each. The proposed issue date is set for 27th June 2024, as the company seeks to advance its financial and strategic objectives. This move indicates an opportunity for investors to engage with the company’s growth trajectory.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
